메뉴 건너뛰기
Journal of Clinical Oncology
Volumn 25, Issue 31, 2007, Pages 5038-5039
Does the decrease in hormone replacement therapy also affect breast cancer risk in the Netherlands? [3]
Author keywords

[No Author keywords available]
Indexed keywords

ESTROGEN; PROGESTERONE;
EID: 36849033436     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.13.7281     Document Type: Letter
Times cited : (39)
References (9)
  • 1
    • 34547233898 scopus 로고    scopus 로고
    • Regional changes in hormone therapy use and breast cancer incidence in California from 2001 to 2004
    • Robbins AS, Clarke CA: Regional changes in hormone therapy use and breast cancer incidence in California from 2001 to 2004. J Clin Oncol 23:3437-3439, 2007
    • (2007) J Clin Oncol , vol.23 , pp. 3437-3439
    • Robbins, A.S.1    Clarke, C.A.2
  • 2
    • 34247241630 scopus 로고    scopus 로고
    • The decrease in breast-cancer incidence in 2003 in the United States
    • Ravdin PM, Cronin KA, Howlader N, et al: The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med 356:1670-1674, 2007
    • (2007) N Engl J Med , vol.356 , pp. 1670-1674
    • Ravdin, P.M.1    Cronin, K.A.2    Howlader, N.3
  • 3
    • 34547166233 scopus 로고    scopus 로고
    • Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy
    • epub ahead of print April 24
    • Katalinic A, Rawal R: Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy. Breast Cancer Res Treat [epub ahead of print April 24, 2007]
    • (2007) Breast Cancer Res Treat
    • Katalinic, A.1    Rawal, R.2
  • 4
    • 3042684006 scopus 로고    scopus 로고
    • Use of oral contraceptives and hormone replacement therapy in the WHO MONICA project
    • Lundberg V, Tolonen H, Stegmayr B, et al: Use of oral contraceptives and hormone replacement therapy in the WHO MONICA project. Maturitas 48:39-49, 2004
    • (2004) Maturitas , vol.48 , pp. 39-49
    • Lundberg, V.1    Tolonen, H.2    Stegmayr, B.3
  • 5
    • 33644616306 scopus 로고    scopus 로고
    • Use of hormones in the menopausal transition period in the Netherlands between 1993 and 1997
    • van Duijnhoven FJ, van Gils CH, Bezemer ID, et al: Use of hormones in the menopausal transition period in the Netherlands between 1993 and 1997. Maturitas 53:462-475, 2006
    • (2006) Maturitas , vol.53 , pp. 462-475
    • van Duijnhoven, F.J.1    van Gils, C.H.2    Bezemer, I.D.3
  • 6
    • 0038108186 scopus 로고    scopus 로고
    • Comparative quantification of health risks conceptual framework and methodological issues
    • Murray CJ, Ezzati M, Lopez AD, et al: Comparative quantification of health risks conceptual framework and methodological issues. Popul Health Metr 1:1, 2003
    • (2003) Popul Health Metr , vol.1 , pp. 1
    • Murray, C.J.1    Ezzati, M.2    Lopez, A.D.3
  • 7
    • 0030843969 scopus 로고    scopus 로고
    • Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet 350:1047-1059, 1997
    • Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet 350:1047-1059, 1997
  • 8
    • 0034700867 scopus 로고    scopus 로고
    • Hormone replacement therapy and accuracy of mammographic screening
    • Kavanagh AM, Mitchell H, Giles GG: Hormone replacement therapy and accuracy of mammographic screening. Lancet 355:270-274, 2000
    • (2000) Lancet , vol.355 , pp. 270-274
    • Kavanagh, A.M.1    Mitchell, H.2    Giles, G.G.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.